Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (ARTACUS)

NCT04349436 is registered in ClinicalTrials.gov with Replimune, Inc. as lead sponsor.

NCT NCT04349436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (ARTACUS)
Lead sponsor
Replimune, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 15, 2020
Completion date
November 30, 2029
Enrollment
69 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, cancer, locally advanced cutaneous squamous cell carcinoma, merkel cell carcinoma